Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
33M
Number of holders
256
Total 13F shares, excl. options
27.1M
Shares change
+1.25M
Total reported value, excl. options
$2.62B
Value change
+$117M
Put/Call ratio
0.42
Number of buys
127
Number of sells
-135
Price
$96.79

Significant Holders of AMEDISYS INC - Common Stock, par value $0.001 per share (AMED) as of Q3 2022

311 filings reported holding AMED - AMEDISYS INC - Common Stock, par value $0.001 per share as of Q3 2022.
AMEDISYS INC - Common Stock, par value $0.001 per share (AMED) has 256 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 27.1M shares of 33M outstanding shares and own 82.16% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (3.04M shares), WELLINGTON MANAGEMENT GROUP LLP (2.61M shares), JPMORGAN CHASE & CO (1.7M shares), RIVERBRIDGE PARTNERS LLC (1.63M shares), AMERIPRISE FINANCIAL INC (1.08M shares), Point72 Asset Management, L.P. (1.07M shares), MACKENZIE FINANCIAL CORP (1M shares), STATE STREET CORP (870K shares), Bellevue Group AG (599K shares), and Bank of New York Mellon Corp (597K shares).
This table shows the top 256 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.